NEW YORK (GenomeWeb) – Molecular diagnostics firm Biocept announced today that it has priced a public offering of approximately 5 million shares of it common stock at $1 per share.

As part of the offering, investors will also receive warrants to purchase up to roughly 3.5 million additional shares at an exercise price of $1.30 per share. The warrants are immediately exercisable and have a term of five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.